Literature DB >> 15541965

Comparison of somatic development and status of conduit after extracardiac Fontan operation in young and older children.

Stanislav Ovroutski1, Peter Ewert, Vladimir Alexi-Meskishvili, Brigitte Stiller, Jan-H Nürnberg, Hashim Abdul-Khaliq, Roland Hetzer, Peter E Lange.   

Abstract

OBJECTIVE: We set out to examine whether the extracardiac Fontan operation (ECFO) in young children is beneficial for the early postoperative course and whether it has a negative impact on the mid-term hemodynamics and growth of the children due to absent growth potential of the prosthetic conduit. Therefore we compared our medium-term experience with ECFO in children under 4 years of age to that in older children regarding the incidence of postoperative complications, somatomotoric development and conduit status. METHODS AND
RESULTS: Between 11/95 and 12/02 ECFO was performed in 30 children under 4 years of age and 21 older children aged 4-13 years. There were no deaths in children under 4 years of age and two older children died. No prolonged support (>72 h) of suprarenin was required in small children compared to 4 older children. In twenty-seven children, who underwent postoperative heart catheterization no pulmonary artery or systemic vein distortion occurred. One re-operation and one transcatheter intervention were performed because of the partial conduit stenosis. During the median follow-up of 4.8 years a manifestly accelerated postoperative weight gain was observed in children operated on under 4 years of age, compared to that in older children (up to the 50 vs. 10th percentile, P<0.05).
CONCLUSIONS: The ECFO could be performed in young children with low morbidity and mortality rates. In the majority of patients, implanted prosthetic grafts maintain stable form without the development of stenosis. Accelerated somatic development, especially in small children, is to be observed after completion of the Fontan circulation.

Entities:  

Mesh:

Year:  2004        PMID: 15541965     DOI: 10.1016/j.ejcts.2004.07.021

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  10 in total

Review 1.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

2.  Anthropometric measures after Fontan procedure: implications for suboptimal functional outcome.

Authors:  Meryl S Cohen; Victor Zak; Andrew M Atz; Beth F Printz; Nelangi Pinto; Linda Lambert; Victoria Pemberton; Jennifer S Li; Renee Margossian; Carolyn Dunbar-Masterson; Brian W McCrindle
Journal:  Am Heart J       Date:  2010-12       Impact factor: 4.749

3.  Deficits in bone density and structure in children and young adults following Fontan palliation.

Authors:  Catherine M Avitabile; David J Goldberg; Babette S Zemel; Jill L Brodsky; Kathryn Dodds; Christina Hayden-Rush; Kevin K Whitehead; Elizabeth Goldmuntz; Jack Rychik; Mary B Leonard
Journal:  Bone       Date:  2015-04-14       Impact factor: 4.398

4.  Normal interstage growth after the norwood operation associated with interstage home monitoring.

Authors:  David A Hehir; Nancy Rudd; Julie Slicker; Kathleen A Mussatto; Pippa Simpson; Shun-Hwa Li; Michele A Frommelt; James S Tweddell; Nancy S Ghanayem
Journal:  Pediatr Cardiol       Date:  2012-04-20       Impact factor: 1.655

5.  Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model.

Authors:  Matthew P Brennan; Alan Dardik; Narutoshi Hibino; Jason D Roh; Gregory N Nelson; Xenophon Papademitris; Toshiharu Shinoka; Christopher K Breuer
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

6.  In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model.

Authors:  Enoch Yeung; Takahiro Inoue; Hiroshi Matsushita; Justin Opfermann; Paige Mass; Seda Aslan; Jed Johnson; Kevin Nelson; Byeol Kim; Laura Olivieri; Axel Krieger; Narutoshi Hibino
Journal:  J Thorac Cardiovasc Surg       Date:  2019-10-09       Impact factor: 5.209

7.  Long-term results of cell-free biodegradable scaffolds for in situ tissue-engineering vasculature: in a canine inferior vena cava model.

Authors:  Goki Matsumura; Naotaka Nitta; Shojiro Matsuda; Yuki Sakamoto; Noriko Isayama; Kenji Yamazaki; Yoshito Ikada
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

8.  Toward a patient-specific tissue engineered vascular graft.

Authors:  Cameron Best; Robert Strouse; Kan Hor; Victoria Pepper; Amy Tipton; John Kelly; Toshiharu Shinoka; Christopher Breuer
Journal:  J Tissue Eng       Date:  2018-03-16       Impact factor: 7.813

Review 9.  Transcatheter interventions in patients with a Fontan circulation: Current practice and future developments.

Authors:  Zakaria Jalal; Marc Gewillig; Younes Boudjemline; Patrice Guérin; Mara Pilati; Gianfranco Butera; Sophie Malekzadeh-Milani; Martina Avesani; Jean-Benoit Thambo
Journal:  Front Pediatr       Date:  2022-08-30       Impact factor: 3.569

Review 10.  Nutritional Management of Patients with Fontan Circulation: A Potential for Improved Outcomes from Birth to Adulthood.

Authors:  Letizia Baldini; Katia Librandi; Chiara D'Eusebio; Antonella Lezo
Journal:  Nutrients       Date:  2022-09-29       Impact factor: 6.706

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.